253 related articles for article (PubMed ID: 26499347)
41. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.
Kim KJ; Pearl PL; Jensen K; Snead OC; Malaspina P; Jakobs C; Gibson KM
Antioxid Redox Signal; 2011 Aug; 15(3):691-718. PubMed ID: 20973619
[TBL] [Abstract][Full Text] [Related]
42. Maternal glutamine supplementation in murine succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.
Brown MN; Walters DC; Schmidt MA; Hill J; McConnell A; Jansen EEW; Salomons GS; Arning E; Bottiglieri T; Gibson KM; Roullet JB
J Inherit Metab Dis; 2019 Sep; 42(5):1030-1039. PubMed ID: 31032972
[TBL] [Abstract][Full Text] [Related]
43. Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria).
Gordon N
Eur J Paediatr Neurol; 2004; 8(5):261-5. PubMed ID: 15341910
[TBL] [Abstract][Full Text] [Related]
44. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.
Gibson KM; Christensen E; Jakobs C; Fowler B; Clarke MA; Hammersen G; Raab K; Kobori J; Moosa A; Vollmer B; Rossier E; Iafolla AK; Matern D; Brouwer OF; Finkelstein J; Aksu F; Weber HP; Bakkeren JA; Gabreels FJ; Bluestone D; Barron TF; Beauvais P; Rabier D; Santos C; Lehnert W
Pediatrics; 1997 Apr; 99(4):567-74. PubMed ID: 9093300
[TBL] [Abstract][Full Text] [Related]
45. Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
Jansen EE; Vogel KR; Salomons GS; Pearl PL; Roullet JB; Gibson KM
J Inherit Metab Dis; 2016 Nov; 39(6):795-800. PubMed ID: 27686230
[TBL] [Abstract][Full Text] [Related]
46. Functional analysis of thirty-four suspected pathogenic missense variants in ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency.
Pop A; Smith DEC; Kirby T; Walters D; Gibson KM; Mahmoudi S; van Dooren SJM; Kanhai WA; Fernandez-Ojeda MR; Wever EJM; Koster J; Waterham HR; Grob B; Roos B; Wamelink MMC; Chen J; Natesan S; Salomons GS
Mol Genet Metab; 2020 Jul; 130(3):172-178. PubMed ID: 32402538
[TBL] [Abstract][Full Text] [Related]
47. Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients.
Knerr I; Gibson KM; Jakobs C; Pearl PL
CNS Spectr; 2008 Jul; 13(7):598-605. PubMed ID: 18622364
[TBL] [Abstract][Full Text] [Related]
48. Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency.
Brown M; Ashcraft P; Arning E; Bottiglieri T; Roullet JB; Gibson KM
Mol Genet Metab; 2019; 128(1-2):109-112. PubMed ID: 31345667
[TBL] [Abstract][Full Text] [Related]
49. Selective involvement of the globus pallidus and dentate nucleus in succinic semialdehyde dehydrogenase deficiency.
Ziyeh S; Berlis A; Korinthenberg R; Spreer J; Schumacher M
Pediatr Radiol; 2002 Aug; 32(8):598-600. PubMed ID: 12136353
[TBL] [Abstract][Full Text] [Related]
50. Age-related phenotype and biomarker changes in SSADH deficiency.
DiBacco ML; Roullet JB; Kapur K; Brown MN; Walters DC; Gibson KM; Pearl PL
Ann Clin Transl Neurol; 2019 Jan; 6(1):114-120. PubMed ID: 30656189
[TBL] [Abstract][Full Text] [Related]
51. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Gibson KM; Gupta M; Pearl PL; Tuchman M; Vezina LG; Snead OC; Smit LM; Jakobs C
Biol Psychiatry; 2003 Oct; 54(7):763-8. PubMed ID: 14512218
[TBL] [Abstract][Full Text] [Related]
52. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
[TBL] [Abstract][Full Text] [Related]
53. Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency.
Ergezinger K; Jeschke R; Frauendienst-Egger G; Korall H; Gibson KM; Schuster VH
Ann Neurol; 2003 Nov; 54(5):686-9. PubMed ID: 14595661
[TBL] [Abstract][Full Text] [Related]
54. The characterization of psychotic symptoms in succinic semialdehyde dehydrogenase deficiency: a review.
Colijn MA
Psychiatr Genet; 2020 Dec; 30(6):153-161. PubMed ID: 33165204
[TBL] [Abstract][Full Text] [Related]
55. Pathophysiology and management of neuropsychiatric symptoms in succinic semialdehyde dehydrogenase deficiency.
Phakey S; Walterfang M
Psychiatr Genet; 2021 Jun; 31(3):100-101. PubMed ID: 33953124
[No Abstract] [Full Text] [Related]
56. Succinic Semialdehyde Dehydrogenase Deficiency: Review of the Natural History Study.
Pearl PL; DiBacco ML; Papadelis C; Opladen T; Hanson E; Roullet JB; Gibson KM
J Child Neurol; 2021 Nov; 36(13-14):1153-1161. PubMed ID: 33393837
[TBL] [Abstract][Full Text] [Related]
57. Neuropathology in succinic semialdehyde dehydrogenase deficiency.
Knerr I; Gibson KM; Murdoch G; Salomons GS; Jakobs C; Combs S; Pearl PL
Pediatr Neurol; 2010 Apr; 42(4):255-8. PubMed ID: 20304328
[TBL] [Abstract][Full Text] [Related]
58. Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine.
Lee HHC; McGinty GE; Pearl PL; Rotenberg A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269750
[TBL] [Abstract][Full Text] [Related]
59. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.
Gropman A
Ann Neurol; 2003; 54 Suppl 6():S66-72. PubMed ID: 12891656
[TBL] [Abstract][Full Text] [Related]
60. Mutation analysis and prenatal diagnosis in a Chinese family with succinic semialdehyde dehydrogenase and a systematic review of the literature of reported ALDH5A1 mutations.
Liu N; Kong XD; Kan QC; Shi HR; Wu QH; Zhuo ZH; Bai QL; Jiang M
J Perinat Med; 2016 May; 44(4):441-51. PubMed ID: 25431891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
